ARTICLE | Company News
Immuneering, Bristol-Myers deal
February 3, 2014 8:00 AM UTC
The companies expanded an existing deal using Immuneering's computational biology methods to assist Bristol-Myers' drug development. Immuneering declined to disclose details, and Bristol-Myers could n...